T

Titan Pharmaceuticals
D

TTNP

4.41000
USD
-0.81
(-15.52%)
مغلق
حجم التداول
769
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
5,866,332
أصول ذات صلة
E
ETON
0.060
(0.39%)
15.410 USD
المزيد
الأخبار المقالات

العنوان: Titan Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.